US Stock Market Move | Withdrawal of experimental drug riluzole application in the EU market leads to a 21% drop in Biohaven (BHVN.US) stock.

23:45 25/04/2025

On Friday, Biohaven (BHVN.US) plunged during trading hours, with the decline widening to 21% at one point, and is now trading at $20.62.

On Friday, Biohaven (BHVN.US) plunged during trading, with the decline reaching 21% at one point, and is now trading at $20.62. On the news front, the company has withdrawn its application for the experimental drug Troriluzole in the EU market. This drug has been studied as a potential treatment for Machado-Joseph disease, OCD, and glioblastoma.

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.